Sponsor Pipeline

Jina Pharmaceuticals Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
3
Phase 3
6
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03671044 A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in… Triple Negative Breast Cancer Recruiting
NCT06867562 Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian… Platinum-Resistant Primary Peritoneal Carcinoma Not Yet Recruiting
NCT06608641 Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients Bipolar 1 Disorder Active, Not Recruiting
Phase 2
NCT06867042 Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active… Ulcerative Colitis (UC) Not Yet Recruiting
NCT06890832 A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel… Metastatic Castration-resistant Prostate Cancer, MCRPC Not Yet Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1) Bipolar Disorder (1) Ulcerative Colitis (1) Ovarian Cancer (1) Prostate Cancer (1)
Get alerts when Jina Pharmaceuticals Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free